Insulet Corporation (FRA:GOV)
Germany · Delayed Price · Currency is EUR 215.10
+2.40 (1.13%)
At close: Jan 30, 2026
Insulet Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 2,522 | 2,072 | 1,697 | 1,305 | 1,099 | 904.4 | |
Revenue Growth (YoY) | 27.11% | 22.07% | 30.02% | 18.79% | 21.50% | 22.51% |
Cost of Revenue | 733.1 | 625.9 | 548.7 | 499.7 | 346.7 | 322.1 |
Gross Profit | 1,789 | 1,446 | 1,148 | 805.6 | 752.1 | 582.3 |
Selling, General & Admin | 1,095 | 917.2 | 734.9 | 567.8 | 466 | 384 |
Research & Development | 270.8 | 219.6 | 205 | 180.2 | 160.1 | 146.8 |
Operating Expenses | 1,365 | 1,137 | 939.9 | 748 | 626.1 | 530.8 |
Operating Income | 423.4 | 308.9 | 208.5 | 57.6 | 126 | 51.5 |
Interest Expense | -53.1 | -42.7 | -36.2 | -36 | -61.7 | -48.1 |
Interest & Investment Income | 39.3 | 39.5 | 28.6 | 9.3 | 0.5 | 3 |
Currency Exchange Gain (Loss) | -2.3 | -2.3 | -0.4 | -1.3 | -2 | 3.2 |
Other Non Operating Income (Expenses) | 16.7 | 0.6 | 0.8 | 0.2 | 0.1 | 0.1 |
EBT Excluding Unusual Items | 424 | 304 | 201.3 | 29.8 | 62.9 | 9.7 |
Merger & Restructuring Charges | 13.5 | - | 11.5 | - | - | - |
Gain (Loss) on Sale of Investments | -2.8 | -3.8 | 1.8 | - | - | - |
Legal Settlements | - | - | - | -20 | - | - |
Other Unusual Items | -123.9 | - | - | - | -42.4 | - |
Pretax Income | 310.8 | 300.2 | 214.6 | 9.8 | 20.5 | 9.7 |
Income Tax Expense | 64.6 | -118.1 | 8.3 | 5.2 | 3.7 | 2.9 |
Earnings From Continuing Operations | 246.2 | 418.3 | 206.3 | 4.6 | 16.8 | 6.8 |
Net Income | 246.2 | 418.3 | 206.3 | 4.6 | 16.8 | 6.8 |
Net Income to Common | 246.2 | 418.3 | 206.3 | 4.6 | 16.8 | 6.8 |
Net Income Growth | -41.51% | 102.76% | 4384.78% | -72.62% | 147.06% | -41.38% |
Shares Outstanding (Basic) | 70 | 70 | 70 | 69 | 68 | 65 |
Shares Outstanding (Diluted) | 73 | 74 | 74 | 70 | 69 | 66 |
Shares Change (YoY) | -4.82% | 0.35% | 5.33% | 1.94% | 3.99% | 5.85% |
EPS (Basic) | 3.50 | 5.97 | 2.96 | 0.07 | 0.25 | 0.11 |
EPS (Diluted) | 3.45 | 5.78 | 2.94 | 0.07 | 0.24 | 0.10 |
EPS Growth | -39.84% | 96.55% | 4338.47% | -72.37% | 140.00% | -47.37% |
Free Cash Flow | 423.5 | 305.4 | 70.1 | -3.9 | -180 | -45 |
Free Cash Flow Per Share | 5.82 | 4.13 | 0.95 | -0.06 | -2.63 | -0.68 |
Gross Margin | 70.93% | 69.79% | 67.67% | 61.72% | 68.45% | 64.39% |
Operating Margin | 16.79% | 14.91% | 12.29% | 4.41% | 11.47% | 5.69% |
Profit Margin | 9.76% | 20.19% | 12.16% | 0.35% | 1.53% | 0.75% |
Free Cash Flow Margin | 16.79% | 14.74% | 4.13% | -0.30% | -16.38% | -4.98% |
EBITDA | 510.9 | 389.7 | 281.3 | 120.8 | 183.4 | 106.9 |
EBITDA Margin | 20.26% | 18.81% | 16.57% | 9.25% | 16.69% | 11.82% |
D&A For EBITDA | 87.5 | 80.8 | 72.8 | 63.2 | 57.4 | 55.4 |
EBIT | 423.4 | 308.9 | 208.5 | 57.6 | 126 | 51.5 |
EBIT Margin | 16.79% | 14.91% | 12.29% | 4.41% | 11.47% | 5.69% |
Effective Tax Rate | 20.79% | - | 3.87% | 53.06% | 18.05% | 29.90% |
Revenue as Reported | 2,522 | 2,072 | 1,697 | 1,305 | 1,099 | 904.4 |
Advertising Expenses | - | 84.3 | 63.1 | 41.2 | 44.1 | 30 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.